Overcoming chemotherapy resistance is a significant challenge in cancer treatment, particularly for aggressive cancers such as acute myeloid leukemia (AML), small cell lung cancer (SCLC), and triple-negative breast cancer. At Dev4All, we support our clients by developing models tailored to their specific scientific questions.
In a project, we generated a chemoresistant cell line to help evaluate in vitro or in vivo whether a novel compound could resensitize tumors to chemotherapy.
👉 At Dev4All, our goal is to help you navigate complex experimental challenges with flexibility and focus.
📩 Interested in our preclinical models or meeting us at an event? Contact Daniel Sanchez Lopez or Céline Martin.
To learn more about the paper, click on the image to view the full post
